Mesodermal and Hematopoietic Differentiation from ES and iPS Cells

Stem Cell Reviews and Reports

Volumn 9, Issue 4, 2013, Pages 422-434

  Inoue Yokoo, Tomoko ^a,b   Tani, Kenzaburo ^c   Sugiyama, Daisuke ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

ES cell; Hematopoietic cell differentiation; iPS cell; Mesoderm induction

Indexed keywords

IPS;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; MESODERM; PLURIPOTENT STEM CELL;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESODERM;

EID: 84881609101     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9388-1     Document Type: Article

References (68)

1. Dzierzak, E., & Speck, N. A. (2008). Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nature Immunology, 9, 129-136.
2. Wang, L. D., & Wagers, A. J. (2011). Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nature Reviews Molecular Cell Biology, 12, 643-655.
3. Mizuochi, C., Fraser, S. T., Biasch, K., Horio, Y., Kikushige, Y., Tani, K., Akashi, K., Tavian, M., & Sugiyama, D. (2012). Intra-aortic clusters undergo endothelial to hematopoietic phenotypic transition during early embryogenesis. PLoS One; in press.
4. Sasaki, T., Mizuochi, C., Horio, Y., Nakao, K., Akashi, K., & Sugiyama, D. (2010). Regulation of hematopoietic cell clusters in the placental niche through SCF/Kit signaling in embryonic mouse. Development, 137, 3941-3952.
5. Sugiyama, D., Kulkeaw, K., Mizuochi, C., Horio, Y., & Okayama, S. (2011). Hepatoblasts comprise a niche for fetal liver erythropoiesis through cytokine production. Biochemical and Biophysical Research Communications, 410, 301-306.
6. Sugiyama, D., Inoue-Yokoo, T., Fraser, S. T., Kulkeaw, K., Mizuochi, C., & Horio, Y. (2011). Embryonic regulation of the mouse hematopoietic niche. Scientific World Journal, 11, 1770-1780.
7. Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154-156.
8. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
9. Orr-Urtreger, A., Bedford, M. T., Do, M. S., Eisenbach, L., & Lonai, P. (1992). Developmental expression of the alpha receptor for platelet-derived growth factor, which is deleted in the embryonic lethal Patch mutation. Development, 115, 289-303.
10. Takakura, N., Yoshida, H., Ogura, Y., Kataoka, H., & Nishikawa, S. (1997). PDGFR alpha expression during mouse embryogenesis: immunolocalization analyzed by whole-mount immunohistostaining using the monoclonal anti-mouse PDGFR alpha antibody APA5. Journal of Histochemistry and Cytochemistry, 45, 883-893.
11. Kabrun, N., Buhring, H. J., Choi, K., Ullrich, A., Risau, W., & Keller, G. (1997). Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development, 124, 2039-2048.
12. Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C., & Keller, G. (1998). A common precursor for hematopoietic and endothelial cells. Development, 125, 725-732.
13. Fehling, H. J., Lacaud, G., Kubo, A., et al. (2003). Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development, 130, 4217-4227.
14. Sakurai, H., Era, T., Jakt, L. M., Okada, M., Nakai, S., & Nishikawa, S. (2006). In vitro modeling of paraxial and lateral mesoderm differentiation reveals early reversibility. Stem Cells, 24, 575-586.
15. Kulkeaw, K., Horio, Y., Mizuochi, C., Ogawa, M., & Sugiyama, D. (2010). Variation in hematopoietic potential of induced pluripotent stem cell lines. Stem Cell Reviews, 6, 381-389.
16. Inoue, T., Kulkeaw, K., Okayama, S., Tani, K., & Sugiyama, D. (2011). Variation in mesodermal and hematopoietic potential of adult skin-derived induced pluripotent stem cell lines in mice. Stem Cell Reviews, 7, 958-968.
17. Niwa, A., Heike, T., Umeda, K., et al. (2011). A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS One, 6, e22261.
18. Morishima, T., Watanabe, K., Niwa, A., et al. (2011). Neutrophil differentiation from human-induced pluripotent stem cells. Journal of Cellular Physiology, 226, 1283-1291.
19. Grigoriadis, A. E., Kennedy, M., Bozec, A., et al. (2010). Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood, 115, 2769-2776.
20. Tolar, J., Park, I. H., Xia, L., et al. (2011). Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome). Blood, 117, 839-847.
21. Burt, R. K., Verda, L., Kim, D. A., Oyama, Y., Luo, K., & Link, C. (2004). Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. The Journal of Experimental Medicine, 199, 895-904.
22. Kyba, M., Perlingeiro, R. C., & Daley, G. Q. (2002). HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell, 109, 29-37.
23. Wang, Y., Yates, F., Naveiras, O., Ernst, P., & Daley, G. Q. (2005). Embryonic stem cell-derived hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 102, 19081-19086.
24. Zhang, X. B., Beard, B. C., Trobridge, G. D., et al. (2008). High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. The Journal of Clinical Investigation, 118, 1502-1510.
25. Hanna, J., Wernig, M., Markoulaki, S., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318, 1920-1923.
26. Lin, J., Fernandez, I., & Roy, K. (2011). Development of feeder-free culture systems for generation of ckit + sca1+ progenitors from mouse iPS cells. Stem Cell Reviews, 7, 736-747.
27. Wang, L., Menendez, P., Shojaei, F., et al. (2005). Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. The Journal of Experimental Medicine, 201, 1603-1614.
28. Nakano, T., Kodama, H., & Honjo, T. (1994). Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science, 265, 1098-1101.
29. Nakano, T., Kodama, H., & Honjo, T. (1996). In vitro development of primitive and definitive erythrocytes from different precursors. Science, 272, 722-724.
30. Motoyama, N., Kimura, T., Takahashi, T., Watanabe, T., & Nakano, T. (1999). bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation. The Journal of Experimental Medicine, 189, 1691-1698.
31. Keller, G., Kennedy, M., Papayannopoulou, T., & Wiles, M. V. (1993). Hematopoietic commitment during embryonic stem cell differentiation in culture. Molecular and Cellular Biology, 13, 473-486.
32. Carotta, S., Pilat, S., Mairhofer, A., et al. (2004). Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells. Blood, 104, 1873-1880.
33. Ma, F., Ebihara, Y., Umeda, K., et al. (2008). Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 105, 13087-13092.
34. Lu, S. J., Feng, Q., Park, J. S., et al. (2008). Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood, 112, 4475-4484.
35. Lengerke, C., Grauer, M., Niebuhr, N. I., et al. (2009). Hematopoietic development from human induced pluripotent stem cells. Annals of the New York Academy of Sciences, 1176, 219-227.
36. Raya, A., Rodriguez-Piza, I., Guenechea, G., et al. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 460, 53-59.
37. Ye, Z., Zhan, H., Mali, P., et al. (2009). Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood, 114, 5473-5480.
38. Era, T., Takagi, T., Takahashi, T., Bories, J. C., & Nakano, T. (2000). Characterization of hematopoietic lineage-specific gene expression by ES cell in vitro differentiation induction system. Blood, 95, 870-878.
39. Eto, K., Murphy, R., Kerrigan, S. W., et al. (2002). Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proceedings of the National Academy of Sciences of the United States of America, 99, 12819-12824.
40. Fujimoto, T. T., Kohata, S., Suzuki, H., Miyazaki, H., & Fujimura, K. (2003). Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood, 102, 4044-4051.
41. Kaufman, D. S., Hanson, E. T., Lewis, R. L., Auerbach, R., & Thomson, J. A. (2001). Hematopoietic colony-forming cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 98, 10716-10721.
42. Gaur, M., Kamata, T., Wang, S., Moran, B., Shattil, S. J., & Leavitt, A. D. (2006). Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. Journal of Thrombosis and Haemostasis, 4, 436-442.
43. Takayama, N., Nishikii, H., Usui, J., et al. (2008). Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood, 111, 5298-5306.
44. Takayama, N., Nishimura, S., Nakamura, S., et al. (2010). Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. The Journal of Experimental Medicine, 207, 2817-2830.
45. Wiles, M. V., & Keller, G. (1991). Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development, 111, 259-267.
46. Lindmark, H., Rosengren, B., Hurt-Camejo, E., & Bruder, C. E. (2004). Gene expression profiling shows that macrophages derived from mouse embryonic stem cells is an improved in vitro model for studies of vascular disease. Experimental Cell Research, 300, 335-344.
47. Moore, K. J., Fabunmi, R. P., Andersson, L. P., & Freeman, M. W. (1998). In vitro-differentiated embryonic stem cell macrophages: a model system for studying atherosclerosis-associated macrophage functions. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1647-1654.
48. Senju, S., Haruta, M., Matsunaga, Y., et al. (2009). Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells, 27, 1021-1031.
49. Lieber, J. G., Webb, S., Suratt, B. T., et al. (2004). The in vitro production and characterization of neutrophils from embryonic stem cells. Blood, 103, 852-859.
50. Yokoyama, Y., Suzuki, T., Sakata-Yanagimoto, M., et al. (2009). Derivation of functional mature neutrophils from human embryonic stem cells. Blood, 113, 6584-6592.
51. Saeki, K., Nakahara, M., Matsuyama, S., et al. (2009). A feeder-free and efficient production of functional neutrophils from human embryonic stem cells. Stem Cells, 27, 59-67.
52. Choi, K. D., Vodyanik, M. A., & Slukvin, I. I. (2009). Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34 + CD43 + CD45+ progenitors. The Journal of Clinical Investigation, 119, 2818-2829.
53. Zou, J., Sweeney, C. L., Chou, B. K., et al. (2011). Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood, 117, 5561-5572.
54. Cho, S. K., Webber, T. D., Carlyle, J. R., Nakano, T., Lewis, S. M., & Zuniga-Pflucker, J. C. (1999). Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 96, 9797-9802.
55. Wada, H., Kojo, S., Kusama, C., et al. (2011). Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells. International Immunology, 23, 65-74.
56. Vodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005). Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood, 105, 617-626.
57. Carpenter, L., Malladi, R., Yang, C. T., et al. (2011). Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. Blood, 117, 4008-4011.
58. de Pooter, R. F., Cho, S. K., Carlyle, J. R., & Zuniga-Pflucker, J. C. (2003). In vitro generation of T lymphocytes from embryonic stem cell-derived prehematopoietic progenitors. Blood, 102, 1649-1653.
59. Schmitt, T. M., de Pooter, R. F., Gronski, M. A., Cho, S. K., Ohashi, P. S., & Zuniga-Pflucker, J. C. (2004). Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nature Immunology, 5, 410-417.
60. Lei, F., Haque, R., Weiler, L., Vrana, K. E., & Song, J. (2009). T lineage differentiation from induced pluripotent stem cells. Cellular Immunology, 260, 1-5.
61. Galic, Z., Kitchen, S. G., Kacena, A., et al. (2006). T lineage differentiation from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 103, 11742-11747.
62. Galic, Z., Kitchen, S. G., Subramanian, A., et al. (2009). Generation of T lineage cells from human embryonic stem cells in a feeder free system. Stem Cells, 27, 100-107.
63. Timmermans, F., Velghe, I., Vanwalleghem, L., et al. (2009). Generation of T cells from human embryonic stem cell-derived hematopoietic zones. Journal of Immunology, 182, 6879-6888.
64. Martin, C. H., Woll, P. S., Ni, Z., Zuniga-Pflucker, J. C., & Kaufman, D. S. (2008). Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood, 112, 2730-2737.
65. Lian, R. H., Maeda, M., Lohwasser, S., et al. (2002). Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. Journal of Immunology, 168, 4980-4987.
66. Watarai, H., Fujii, S., Yamada, D., et al. (2010). Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells. The Journal of Clinical Investigation, 120, 2610-2618.
67. Ni, Z., Knorr, D. A., Clouser, C. L., et al. (2011). Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of Virology, 85, 43-50.
68. Szabo, E., Rampalli, S., Risueno, R. M., et al. (2010). Direct conversion of human fibroblasts to multilineage blood progenitors. Nature, 468, 521-526.